Inhibition of human platelet thromboxane generation by aspirin in the absence of measurable drug levels in peripheral blood
- 15 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (10) , 1839-1841
- https://doi.org/10.1016/0006-2952(85)90658-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- A regimen for low-dose aspirin?BMJ, 1982
- PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINKThe Lancet, 1982
- DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESISThe Lancet, 1981
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segmentsThrombosis Research, 1980
- Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.Stroke, 1980
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- The Inhibitory Effect of Aspirin on Platelet and Vascular Prostaglandins in Rats cannot be Completely DissociatedBritish Journal of Haematology, 1979
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Absorption Kinetics of Aspirin in Man follow Oral Administration of an Aqueous SolutionJournal of Pharmaceutical Sciences, 1972